Literature DB >> 19725043

Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation.

Ece Dilber Gamsiz1, Lee Miller, Avinash G Thombre, Imran Ahmed, Rebecca Lyn Carrier.   

Abstract

A model was developed for predicting the influence of cyclodextrins (CDs) delivered as a physical mixture with drug on oral absorption. CDs are cyclic oligosaccharides which form inclusion complexes with many drugs and are often used as solubilizing agents. The purpose of this work is to compare the simulation predictions with in vitro as well as in vivo experimental results to test the model's ability to capture the influence of CD on key processes in the gastrointestinal (GI) tract environment. Dissolution and absorption kinetics of low solubility drugs (Naproxen and Nifedipine) were tested in the presence and absence of CD in a simulated gastrointestinal environment. Model predictions were also compared with in vivo experimental results (Glibenclamide and Carbamazepine) from the literature to demonstrate the model's ability to predict oral bioavailability. Comparisons of simulation and experimental results indicate that a model incorporating the influence of CD (delivered as a physical mixture) on dissolution kinetics and binding of neutral drug can predict trends in the influence of CD on bioavailability. Overall, a minimal effect of CD dosed as a physical mixture was observed and predicted. Modeling may aid in enabling rational design of CD containing formulations. 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19725043     DOI: 10.1002/bit.22524

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  3 in total

Review 1.  The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.

Authors:  Arik Dahan; Jonathan M Miller
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

2.  Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.

Authors:  Victor Mangas-Sanjuan; Jorge Gutiérrez-Nieto; Magdalena Echezarreta-López; Isabel González-Álvarez; Marta González-Álvarez; Vicente-Germán Casabó; Marival Bermejo; Mariana Landin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.569

3.  Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations.

Authors:  Avital Beig; Riad Agbaria; Arik Dahan
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.